XT
NNVC icon

XTX Topco’s NanoViricides NNVC Stock Holding History

XTX Topco’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.3K Buy
35,432
+16,546
+88% +$17.3K ﹤0.01% 3435
2025
Q4 		$21.3K Buy
18,886
+8,110
+75% +$11.4K ﹤0.01% 3045
2025
Q3 		$15.4K Sell
10,776
-10,367
-49% -$15.5K ﹤0.01% 2372
2025
Q2 		$29.6K Sell
21,143
-30,109
-59% -$41.1K ﹤0.01% 2113
2025
Q1 		$60K Buy
+51,252
New +$65K ﹤0.01% 1965
2023
Q4 		– Sell
-10,214
Closed -$13.7K – 1940
2023
Q3 		$13.7K Buy
+10,214
New +$14.4K ﹤0.01% 1407

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco's NNVC Position: Q1 2026 in Review

XTX Topco increased its NanoViricides (NNVC) stake by 88% in Q1 2026, buying an estimated $17.3K and bringing the position to 35,432 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3435.

XTX Topco first reported a position in NNVC in Q3 2023 and has held it in 6 quarters since. The position peaked at $60K in Q1 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q1 2026.

  • XTX Topco held 35,432 shares of NanoViricides worth $32.3K as of Q1 2026.
  • XTX Topco bought 16,546 NanoViricides shares in Q1 2026, an estimated $17.3K.
  • NanoViricides made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3435 holding.
  • XTX Topco first reported a position in NanoViricides in Q3 2023 and has held it in 6 quarters since.
  • XTX Topco's NanoViricides position peaked at $60K in Q1 2025.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.